A new term for Dr. Mona Nemer; U of T’s response to monkeypox outbreak paves the way for collaborations with Canadian and international groups, a rebound in Canadian angel investment stats, and more.
Organization: COVID-19 Immunity Task Force
The Short Report – April 6, 2022: Ontario Greens issue supply chain strategy for EVs, federal funding for climate and pandemic research, a review of Canada’s Remote Sensing Space Systems Act, and more
Green Party of Ontario releases EV strategy two months ahead of provincial election, research gets a boost through the New Frontiers in Research Fund, a review of Canada’s Remote Sensing Space Systems Act is completed, and more.
The Short Report – July 21, 2021: Canada’s fast-growing tech talent, UBC joins global autism initiative, and more
A CBRE report shows Canada has some of the fastest growing tech talent pools In North America, UBC joins a global network to personalize autism care, and more.
The Short Report – June 9, 2021: Ontario boosts high tech innovation with $100M VC fund, grants for Dalhousie’s battery pioneers, a major donation to U of Guelph’s groundwater research, and more
A new Ontario venture fund to drive innovation and growth, the largest Alliance Grant in Dalhousie U’s history to make electric vehicles more accessible, a $10 million gift to UGuelph’s G360 Institute boosts global groundwater research, and more.
The Short Report – Nov. 4th, 2020: Tracking international travellers for COVID-19; $26 million for doctoral researchers, and more…
Surveillance border study at Toronto’s airport continues to track international travellers for COVID-19; the Canadian Space Agency supports the launch of two lunar technology payloads to the moon.
The Short Report – Oct. 7, 2020: Digital health solutions continue to accelerate, U of A prof wins Nobel Prize, and more
The COVID-19 Immunity Task Force will study the prevalence of COVID-19 antibodies among Canadians over 50 years old; Dr. Mona Nemer is appointed to a second term as Chief Science Officer, and digital health technology continues to accelerate in Canada.
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…